Liberty Mutual Group Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-8,894
| Closed | -$1.24M | – | 870 |
|
2018
Q3 | $1.24M | Hold |
8,894
| – | – | 0.03% | 288 |
|
2018
Q2 | $1.1M | Sell |
8,894
-1
| -0% | -$124 | 0.03% | 333 |
|
2018
Q1 | $991K | Hold |
8,895
| – | – | 0.03% | 385 |
|
2017
Q4 | $1.06M | Sell |
8,895
-198
| -2% | -$23.7K | 0.03% | 421 |
|
2017
Q3 | $1.28M | Sell |
9,093
-5,034
| -36% | -$706K | 0.07% | 333 |
|
2017
Q2 | $1.72M | Buy |
14,127
+1,762
| +14% | +$214K | 0.07% | 372 |
|
2017
Q1 | $1.5M | Sell |
12,365
-3,967
| -24% | -$481K | 0.06% | 475 |
|
2016
Q4 | $2M | Buy |
16,332
+839
| +5% | +$103K | 0.07% | 354 |
|
2016
Q3 | $1.9M | Sell |
15,493
-529
| -3% | -$64.8K | 0.07% | 355 |
|
2016
Q2 | $1.87M | Buy |
16,022
+1,156
| +8% | +$135K | 0.07% | 335 |
|
2016
Q1 | $2.07M | Buy |
14,866
+1,344
| +10% | +$187K | 0.09% | 258 |
|
2015
Q4 | $2.58M | Buy |
13,522
+409
| +3% | +$78K | 0.1% | 262 |
|
2015
Q3 | $2.05M | Sell |
13,113
-46
| -0.3% | -$7.19K | 0.08% | 313 |
|
2015
Q2 | $2.38M | Sell |
13,159
-3,933
| -23% | -$711K | 0.08% | 293 |
|
2015
Q1 | $2.96M | Buy |
17,092
+835
| +5% | +$145K | 0.09% | 244 |
|
2014
Q4 | $3.01M | Buy |
16,257
+178
| +1% | +$32.9K | 0.09% | 237 |
|
2014
Q3 | $2.67M | Sell |
16,079
-387
| -2% | -$64.2K | 0.09% | 272 |
|
2014
Q2 | $2.57M | Sell |
16,466
-1,661
| -9% | -$260K | 0.08% | 294 |
|
2014
Q1 | $2.76M | Buy |
18,127
+2,248
| +14% | +$342K | 0.09% | 230 |
|
2013
Q4 | $2.11M | Buy |
15,879
+4,071
| +34% | +$541K | 0.07% | 301 |
|
2013
Q3 | $1.37M | Buy |
11,808
+2,511
| +27% | +$292K | 0.05% | 449 |
|
2013
Q2 | $857K | Buy |
+9,297
| New | +$857K | 0.03% | 632 |
|